Employee Benefit News for School, City and County Employers

FDA Authorizes COVID-19 At-home Rapid Test

Written by Erin Woulfe | Oct 14, 2021 6:45:00 PM

1 minute read

The U.S. Food and Drug Administration (FDA) approved a new over-the-counter COVID-19 antigen test to increase customer testing during the pandemic. The Flowflex COVID-19 Home Test can provide results in a little as 15 minutes.

A COVID-19 antigen test can detect specific proteins in the virus by testing the nasal fluid or a saliva sample. Most at-home antigen tests are authorized for serial testing, which tests the same individual more than once within a few days.

The Flowflex’s authorization will boost the availability of rapid at-home tests and double at-home testing in the U.S. Availability and pricing of at-home COVID-19 tests may vary, check your major local retailer.

To learn more about self-testing and reporting results, visit the Centers for Disease Control and Prevention’s website.

Download the bulletin for more details.

This blog is intended to be a compilation of information and resources pulled from federal, state, and local agencies. This is not intended to be legal advice. For up to the minute information and guidance on COVID-19, please follow the guidelines of the Centers for Disease Control and Prevention (CDC) and your local health organizations.